Document is current
Any future updates will be listed below
-
Authors
Schröper, Tobias
Mehrkens, Dennis
Leiss, Veronika
Tellkamp, Frederik
Engelhardt, Stefan
Herzig, Stefan
Birnbaumer, Lutz
Nürnberg, Bernd
Matthes, Jan
-
Funding
Funding for this research was provided by:
Graduate Program in Pharmacology and Experimental Therapeutics of the University of Cologne and Bayer Schering Pharma (C25)
Graduate Program in Pharmacology and Experimental Therapeutics of the University of Cologne and Bayer Schering Pharma (C25)
Deutsche Forschungsgemeinschaft (TRR 259 (397484323))
Deutsche Forschungsgemeinschaft (NU 53/9-2)
Deutsche Forschungsgemeinschaft (NU 53/9-2)
Intramural Research Program of the NIH (Z01-ES-101643)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 8 August 2023
Accepted: 26 September 2023
First Online: 16 October 2023
Declarations
:
: The manuscript does not contain clinical studies or patient data. The responsible federal state authority approved animal breeding, maintenance, and experiments (Landesamt fuer Natur-, Umwelt- und Verbraucherschutz Nordrhein-Westfalen; references: 84–02.05.20.12.294, 84–02.05.20.13.060, and 84–02.04.2016.A422). All animal experiments complied with the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.
: The authors declare no competing interests.
